Jean R Clemenceau

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Diffusion Weighted Imaging

Inflammatory Response

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

The journal of pathology. Clinical research

Cancer research

Cleveland Clinic Lerner College of Medicine of Case Western Reserve University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

United States

PHD :: Molecular Medicine

Baylor University

United States

BSC

Publications

Sunho Park, John D Karalis, Changjin Hong, Jean R Clemenceau, Matthew R Porembka, In-Ho Kim, Sung Hak Lee, Sam C Wang, Jae Ho Cheong, Tae Hyun Hwang
ACTA2 Expression Predicts Survival and Is Associated with Response to Immune Checkpoint Inhibitors in Gastric Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
Sunho Park, John D Karalis, Changjin Hong, Jean R Clemenceau, Matthew R Porembka, In-Ho Kim, Sung Hak Lee, Sam C Wang, Jae Ho Cheong, Tae Hyun Hwang
ACTA2 expression predicts survival and is associated with response to immune checkpoint inhibitors in gastric cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Hongming Xu, Yoon-Jin Cha, Jean R Clemenceau, Jinhwan Choi, Sung Hak Lee, Jeong Hyun Kang, Tae Hyun Hwang
Spatial analysis of tumor-infiltrating lymphocytes in histological sections using deep learning techniques predicts survival in colorectal carcinoma. The journal of pathology. Clinical research 8 (4) (2022)
Sam C Wang, Yunku Yeu, Suntrea T G Hammer, Shu Xiao, Hao Zhu, Changjin Hong, Jean R Clemenceau, Lynn Y Yoon, Ibrahim Nassour, Jeanne Shen, Deepak Agarwal, Scott I Reznik, John C Mansour, Adam C Yopp, Tae Hyun Hwang, Matthew R Porembka
Hispanic/Latino Patients with Gastric Adenocarcinoma Have Distinct Molecular Profiles Including a High Rate of Germline CDH1 Variants. Cancer research 80 (11) (2020)